Event News & Resources
Neuro-Bio attends the Adoreum Club lunch in Zurich – Tuesday 1st April!
We’d like to thank Marcus Watson and the Adoreum team for inviting us to their recent Club Lunch at the Dolder Grand Hotel in Zurich on Tuesday 1st April, where the focus was on the benefits and challenges of investing in dementia. Baroness Susan...
New partnership for Neuro-Bio
Weronkia Buczek has been awarded a MRC DiMeN Doctoral Training Partnership for her PhD. The title of the project is ‘Molecular characterisation of the in vivo targets and mechanism of action of an acetylcholinesterase-derived peptide upregulated in Alzheimer’s...
Will Ponting joins the Biomarker team
Neuro-Bio welcomes Will Ponting as part of the Biomarker team. Will has recently graduated from the University of Reading with a BSc degree in Psychology and is joining us to gain valuable experience working in a laboratory setting. He is very interested in...
Training in the latest ISO standards
January 2020, all of Neuro-Bio are receiving training in the latest ISO standards for Quality Management and Medical Device R&D. This training and the subsequent accreditation in ISO9001/13485 will enable the company to continue to progress with it’s biomarker...
Congratulation to Sara and Family
Neuro-Bio wish to congratulate Sara, Mark and family on the arrival of Maximilian Stow-Garcia, born on the 17th of December.
Heather Bunney visited Neuro Bio
On Thursday 21st November we had the pleasure of welcoming Heather Bunney back to the Neuro-Bio team to deliver a team building programme. Heather had prepared multiple, challenging team building activities, in which everyone participated in and thoroughly enjoyed....
Neuro-Bio and BMB hosted an event in London
“Disruptive science and how to explore it, value it and sell it” Event YouTube Video Neuro-Bio and BMB hosted an event in London on 16th October. In the event, experts in the business of biotech and neurodegenerative disease research formed a panel to discuss the main...